| Previous close | 3.1000 |
| Open | 3.0500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 27.50 |
| Expiry date | 2025-12-19 |
| Day's range | 3.0500 - 3.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksPharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
ZacksPfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.
© 2024 Yahoo. All rights reserved.